BREWIN DOLPHIN LTD - CYCLACEL PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
BREWIN DOLPHIN LTD ownership history of CYCLACEL PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2020$2,155
-42.4%
5,5860.0%0.00%
Q4 2019$3,743
+69.0%
5,5860.0%0.00%
Q3 2019$2,215
-26.6%
5,5860.0%0.00%
Q2 2019$3,019
-42.2%
5,5860.0%0.00%
-100.0%
Q1 2019$5,223
+54.5%
5,5860.0%0.00%
Q4 2018$3,380
-55.8%
5,5860.0%0.00%
-100.0%
Q3 2018$7,653
-3.5%
5,5860.0%0.00%0.0%
Q2 2018$7,932
+5.2%
5,5860.0%0.00%0.0%
Q1 2018$7,541
-22.4%
5,5860.0%0.00%0.0%
Q4 2017$9,720
-4.9%
5,5860.0%0.00%0.0%
Q3 2017$10,2225,5860.00%
Other shareholders
CYCLACEL PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 559,900$1,025,0000.31%
Virtu Financial LLC 117,644$215,0000.01%
WEDBUSH SECURITIES INC 27,400$50,0000.01%
TWO SIGMA SECURITIES, LLC 28,471$52,0000.01%
BREWIN DOLPHIN LTD 5,586$10,2220.00%
UBS Group AG 3,355$6,0000.00%
D'Orazio & Associates, Inc. 100$00.00%
DIMENSIONAL FUND ADVISORS LP 14,749$27,0000.00%
GEODE CAPITAL MANAGEMENT, LLC 21,692$39,0000.00%
DEUTSCHE BANK AG\ 503$00.00%
View complete list of CYCLACEL PHARMACEUTICALS INC shareholders